Past Events & Conferences

Virtual Roundtable Discussion With Key Opinion Leaders in Psychiatry From Harvard and Imperial

Small Pharma Roundtable

Distinguished psychiatrists Jerry Rosenbaum, MD, Professor of Psychiatry at Harvard Medical School, and David Erritzoe, MD, PhD, Imperial College London, joined Small Pharma’s Chief Medical & Scientific Officer, Carol Routledge, PhD to discuss the potential of short-duration psychedelics as a treatment for depression and other mental health conditions.  The experts shared insights into:

 

  • Major Depressive Disorder diagnosis, existing treatment options, and long-term management
  • The potential of short-duration psychedelics as a clinical treatment for depression and other mental health conditions
  • Mental health care delivery and infrastructure implications

Watch the roundtable discussion here. 

About Small Pharma

We’re a biotechnology company researching and developing short-acting psychedelics with supportive therapy for mental health conditions.

Register for Company Updates


    Corporate Presentation

    Follow us: